Creo Medical Group plc ("Creo" or the "Group"), the medical device company specialising in advanced energy solutions for therapeutic endoscopy, today announces the clinical use of SpydrBlade Flex in ...
LONDON - Creo Medical (TASE:BLWV) Group plc (AIM:CREO) has received U.S. Food and Drug Administration clearance for its SpydrBlade Flex (NASDAQ:FLEX) device, the company announced in a press release ...
Creo Medical anticipates increased adoption of the SpydrBlade Flex following further regulatory clearances, including FDA approval for a US commercial launch. The company’s statement emphasized the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results